Delivery Order SPE2DB22D6029-SPE2DB23FU1ME
- Not listed
- This federal contract award is for the delivery of LUMASON 25 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The $1,197.24 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a period of performance through July 16, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is a delivery order valued at $5,546.58 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LUMASON 25 MG VIALS, a medical product, and has a firm fixed price. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $1,159.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,160,042 units of the medication Lumason 25 mg vials. The contract has a firm fixed price and a period of performance extending through May 7, 2025. This award is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.10 firm fixed-price delivery order is for the supply of LUMASON 25 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX,...
- This federal contract award, valued at $4,090.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMASON 25 MG VIALS, a medical product, with a performance period that extends through May 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00....
- The Defense Logistics Agency awarded a $1,493.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials, with an ultimate completion date of June 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contract will be fulfilled from the vendor's location in Conshohocken,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of OPTISON VIAL 3ML pharmaceutical products to the U.S. government. The contract, valued at $2,149.36, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $37,349.94 and is a Firm Fixed Price Delivery Order. The contract is for the supply of LUNSUMIO 30 MG/30 ML VIAL 30ML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.82 firm fixed-price delivery order is for the supply of Optison vials, a medical product used for ultrasound imaging. The contract has an ultimate completion date of December 30, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,200.00 firm fixed-price delivery order is for OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of July 1, 2025 and was awarded on June 30, 2025. This award is not set aside. Amerisourcebergen Drug Corp is the prime contractor and holds a $999,999,999.00 Indefinite...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB23FU1MEDelivery Order
This federal contract award is for pharmaceutical products, specifically LUMASON 25 MG VIALS, to the Defense Logistics Agency (DLA) by prime contractor AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract has a ceiling value of $5,810.00 and is a Delivery Order with a Firm Fixed Price pricing type. The award date is August 7, 2023 and the ultimate completion date is August 8, 2023. The contract is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025 to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/7/23 |